Fragile X syndrome epidemiology and demographics: Difference between revisions
No edit summary |
|||
Line 10: | Line 10: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
The [[prevalence]] of Fragile X syndrome is approximately 1 in 5000 men and 1 in 4000-6000 women worldwide, determined by [[Molecular Biology|molecular]] [[assays]]. | The [[prevalence]] of Fragile X syndrome is approximately 1 in 5000 men and 1 in 4000-6000 women worldwide, determined by [[Molecular Biology|molecular]] [[assays]]. | ||
Fragile X Syndrome has been diagnosed in approximately 3 percent of boys with significant [[Neurodevelopmental disorders|neurodevelopmenta]]<nowiki/>l [[disorders]]. | Fragile X Syndrome has been diagnosed in approximately 3 percent of boys with significant [[Neurodevelopmental disorders|neurodevelopmenta]]<nowiki/>l [[disorders]]. | ||
==References== | ==References== |
Latest revision as of 12:55, 16 September 2021
Fragile X syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Fragile X syndrome epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Fragile X syndrome epidemiology and demographics |
Fragile X syndrome epidemiology and demographics in the news |
Risk calculators and risk factors for Fragile X syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The prevalence of female carrier status has been estimated to be as high as 1 in 130-250 population; the prevalence of male carrier status is estimated to be 1 in 250-800 population. However, disease manifestations are seen in lesser number of people.
Epidemiology and Demographics
The prevalence of Fragile X syndrome is approximately 1 in 5000 men and 1 in 4000-6000 women worldwide, determined by molecular assays. Fragile X Syndrome has been diagnosed in approximately 3 percent of boys with significant neurodevelopmental disorders.